IP Library Granted Patent US 8,697,053
Granted Patent B2
US 8,697,053 · App. 12/421,449 · Granted Apr 15, 2014

Compositions and methods for inhibiting pathogenic growth

Inventors: Bryan E. Garner (Amarillo, TX); Douglas R. Ware (Indianapolis, IN)
Assignee: Nutrition Physiology Company, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,053
App. No.
12/421,449
Granted
Apr 15, 2014
Kind
B2
Abstract

The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus acidophilus in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.

Claims (7)

1. A method of inhibiting an intestinal pathogenic infection in a ruminant, the method comprising:

(a) administering to the ruminant a composition that inhibits the growth of the pathogenic bacterium in the ruminant, said composition comprising a lactic acid producing bacterium and a lactate utilizing bacterium, wherein the ratio in colony forming unit (CFU) between said lactic acid producing bacterium and said lactate utilizing bacterium in said composition is about 1:1 (CFU lactic acid producing bacterium : CFU lactate utilizing bacterium ), and

(b) assessing the effects of pathogen reduction by said composition,

said lactic acid producing bacterium being the LA51 strain, said lactate utilizing bacterium being the PF24 strain, wherein said LA51 and PF24 strains are each administered to said ruminant at 1×10 9 CFU/day.

2. The method of claim 1 , wherein the pathogenic bacterium is selected from the group consisting of Escherichia coli, Salmonella spp., and Staphylococcus aureus.

3. The method of claim 2 , wherein the pathogenic bacterium is Escherichia coli.

4. The method of claim 3 , wherein the Escherichia coli is Escherichia coli O157:H7.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: WARE, DOUGLAS R.; GARNER, BRYAN
To: NUTRITION PHYSIOLOGY CORPORATION
Reel/Frame 039013/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: NUTRITION PHYSIOLOGY COMPANY, LLC
To: CHR. HANSEN A/S
Reel/Frame 038287/0072 →
SECURITY AGREEMENT Recorded Jul 19, 2012
From: NUTRITION PHYSIOLOGY COMPANY, LLC
To: FIFTH THIRD BANK
Reel/Frame 028597/0811 →
Continuity (10)
Division 10905215 · Dec 21, 2004
Division 10288487 · Nov 6, 2002
Continuation 10273141 · Oct 18, 2002
Continuation 12421449
Continuation 11160470 · Jun 24, 2005
Continuation 10288487
Continuation 10273141
Provisional Application 60319054 · Jan 8, 2002
Provisional Application 60319587 · Oct 1, 2002
Related Publication 20120107288A1 · May 3, 2012